基本資料
種類: ETF
費用比率%: 0.95
資產淨值: 1,145.75
成立日期: 23/01/2007
 
分析
市值分佈:
12.42%
大市值
6.54%
中市值
3.45%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 01/08/2026 05:21) 總持有投資項目: 1261  
0%
 
100%
     10大 (1.29%)
代號 名稱 佔比% 持有日期
KROSKeros Therapeutics0.00329/07/2026
TGTredegar Corp0.00328/07/2026
CBFVCB Financial Services0.00330/06/2026
CRD.ACrawford & Company0.00329/07/2026
TARAProtara Therapeutics0.00328/07/2026
GEMIGemini Space Station Inc0.00330/06/2026
NMRANeumora Therapeutics0.00330/06/2026
BCBPBCB Bancorp0.00330/06/2026
MASS908 Devices0.00328/07/2026
MFINMedallion Financial Corp0.00330/06/2026
PLXProtalix BioTherapeutics0.00330/06/2026
SHAZSharonAI Holdings, Inc.0.00328/07/2026
OBIOOrchestra BioMed Holdings0.00330/06/2026
ASURAsure Software0.00328/07/2026
BHBiglari Holdings0.00328/07/2026
LWAYLifeway Foods0.00330/06/2026
SABSSAB Biotherapeutics0.00230/06/2026
MDVModiv Industrial0.00230/06/2026
ACDCProFrac Holding Corp0.00230/06/2026
CFBKCF Bankshares0.00230/06/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16    17    18    19    20    21    22    23    24    25    26    27    28    29    30    31    32    33    34    35    36    37    38    39    40    41    42    43    44    45    46    47    48    49    50    51    52   53    54    55    56    57    58    59    60    61    62    63    64  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.